Correction to: Silent hypoxia: higher NO in red blood cells of COVID-19 patients.

Autor: Mortaz E; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NLRTLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Malkmohammad M; Tracheal Disease Research Center, National Research Institute of Tuberculosisand Lung Diseases (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran. mmalekmohammad@yahoo.com., Jamaati H; Chronic Respiratory Diseases Research Center, National Research Institute ofTuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Naghan PA; Chronic Respiratory Diseases Research Center, National Research Institute ofTuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Hashemian SMR; Chronic Respiratory Diseases Research Center, National Research Institute ofTuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NLRTLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Varahram M; Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zaheri H; Chronic Respiratory Diseases Research Center, National Research Institute ofTuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Chousein EGU; University of Health Sciences Turkey, Yedikule Chest Diseases and Thoracic Surgery, Education and research Hospital, Department of pulmonology, Istanbul, Turkey., Folkerts G; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands., Adcock IM; Cell and Molecular Biology Group, Airways Disease Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2020 Nov 10; Vol. 20 (1), pp. 294. Date of Electronic Publication: 2020 Nov 10.

Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy.

Autor: Malekmohammad M; Tracheal Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Folkerts G; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands., Kashani BS; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Naghan PA; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Dastenae ZH; Tracheal Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran., Khoundabi B; Helal-e-Iran Applied Science Higher Education Institute Red crescents society of Iran, Tehran, Iran., Garssen J; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands., Mortaz E; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. emortaz@gmail.com., Adcock IM; Cell and Molecular Biology Group, Airways Disease Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2019 Nov 05; Vol. 19 (1), pp. 197. Date of Electronic Publication: 2019 Nov 05.

Nutrition and lung cancer: a case control study in Iran.

Autor: Hosseini M, Naghan PA; Lung Transplantation Research Center, National Research and Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Shaheed Bahonar Ave, Darabad, Tehran 1955841452, Iran. prs_adimi@yahoo.com., Jafari AM, Yousefifard M, Taslimi S, Khodadad K, Mohammadi F, Sadr M, Rezaei M, Mortaz E, Masjedi MR

Publikováno v: BMC cancer [BMC Cancer] 2014 Nov 21; Vol. 14, pp. 860. Date of Electronic Publication: 2014 Nov 21.

Opium could be considered an independent risk factor for lung cancer: a case-control study.

Autor: Masjedi MR; Clinical Tuberculosis Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Naghan PA, Taslimi S, Yousefifard M, Ebrahimi SM, Khosravi A, Karimi S, Hosseini M, Mortaz E

Publikováno v: Respiration; international review of thoracic diseases [Respiration] 2013; Vol. 85 (2), pp. 112-8. Date of Electronic Publication: 2012 Jul 03.

Environmental risk factors for lung cancer in Iran: a case-control study.

Autor: Hosseini M; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. mhossein110@yahoo.com, Naghan PA, Karimi S, SeyedAlinaghi S, Bahadori M, Khodadad K, Mohammadi F, Kaynama K, Masjedi MR

Publikováno v: International journal of epidemiology [Int J Epidemiol] 2009 Aug; Vol. 38 (4), pp. 989-96. Date of Electronic Publication: 2009 Jul 09.